An official website of the United States government

This repository is under review for potential modification in compliance with Administration directives.
Citation
Krischer, Jeffrey (2022). Long-Term Investigative Follow-Up in TrialNet Study (TN16) (Version 2) [Dataset] NIDDK Central Repository. https://doi.org/10.58020/w3gs-0421
Data Availability Statement
Data from the Long-Term Investigative Follow-Up in TrialNet Study (TN16) [(Version 2) https://doi.org/10.58020/w3gs-0421] reported here are available for request at the NIDDK Central Repository (NIDDK-CR) website, Resources for Research (R4R), https://repository.niddk.nih.gov/.
Acknowledgement Statement
This research was performed using resources generated by the Type 1 Diabetes TrialNet Study Group, a clinical trials network funded through a cooperative agreement by the National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Allergy and Infectious Diseases (NIAID), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the Juvenile Diabetes Research Foundation (JDRF) and supplied by NIDDK Central Repository (NIDDK-CR). This manuscript was not prepared under the auspices of the TrialNet network and does not necessarily represent the opinions or views of TrialNet, NIDDK-CR, or NIH.
Data Package Version
Version 2 (Updated on: Jun 09, 2022)
Publications
Explore publications resulting from the use of study resources
View publications (0)

General Description

The LIFT Study is available nationwide to TrialNet participants who either:

  • Developed diabetes while being monitored in the Pathway to Prevention Study or during participation in any prevention trial. The purpose is to study people early in the disease process

  • Participated in any new onset studies. The purpose is to learn more about diabetes and if there are any long-term effects—good or bad—from the treatments used in these studies

Participants will be asked to return to a TrialNet site annually or semi- annually, based on their ongoing ability to produce insulin. Visits will include metabolic testing (i.e., Oral Glucose Tolerance Test and/or Mixed Meal Tolerance Test), HbAc1, and possibly other blood or urine tests.

Primary Objectives

To study subjects early in the Type 1 Diabetes process, and to study if there are any long-term effects from the treatments used in previous new onset studies.

Inclusion Criteria

Inclusion Criteria:

  • Subjects that were previously enrolled in a TrialNet study for people newly diagnosed with type 1 diabetes

  • Subjects that developed type 1 diabetes while participating in the Pathway to Prevention Study or a TrialNet prevention study.

Outcome

This study is ongoing.

Research Area

Diabetes

Study Type

Observational

Condition

Type 1 Diabetes Mellitus

Medication or Intervention Agent

None

Procedure

Mixed Meal Tolerance Test, Glucose Tolerance Test

Keywords

Diabetes Mellitus, Type 1

NIDDK Division

Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM)

There are currently no public documents available

Permitted Use(s) of the Resources
  • Use is allowed only for the specified disease(s), disorder(s), condition(s), or research area(s): Type 1 Diabetes Mellitus; Related Complications; Autoimmune Diseases

  • Use does not allow sharing for commercial purposes

  • Use does not allow cell-line creation

Certificate of Confidentiality
  • This NIDDK-funded study is covered by a Certificate of Confidentiality. More information on what this means to Requestors is available in the NIH FAQ.

Non-Public Documents (0)
There are currently no non-public documents available
Datasets (0)
There are currently no datasets available
Specimens (58,830)
Specimens Table
Specimen
Count
PB-PBMC17024
Plasma26734
Serum9202
Whole Blood5870